Trendlines builds war chest; eyes combined markets of Israel, Singapore, China
The medical and agricultural technology firm is raising funds to better support its startups and help them penetrate the three markets.
THE Trendlines Group is building its war chest. The Israel-based, Catalist-listed medical and agricultural technology (medtech, agritech) incubator is raising funds to better support its startups and help them penetrate the three markets it has set its sights on: Israel, Singapore and China.
Fresh from announcing a joint venture (JV) with Chinese private equity firm Shoushan Wealth Holdings last week, which will help finance its portfolio companies and support them in their expansion into China, Trendlines is also raising additional funds for medtech companies globally.
Todd Dollinger, co-chairman and chief executive officer (CEO) of the company, told The Business Times: "With our new China JV, the fund-raises that are in process are in US dollars and renminbi, and projected to reach a combined US$100 million in funds."
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance